It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GUTS’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GUTS’s TA Score shows that 5 TA indicator(s) are bullish while IPSC’s TA Score has 6 bullish TA indicator(s).
GUTS (@Biotechnology) experienced а +6.36% price change this week, while IPSC (@Biotechnology) price change was +10.98% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +3.00%. For the same industry, the average monthly price growth was +5.57%, and the average quarterly price growth was -1.69%.
GUTS is expected to report earnings on Aug 13, 2025.
IPSC is expected to report earnings on Aug 07, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
GUTS | IPSC | GUTS / IPSC | |
Capitalization | 86M | 49.5M | 174% |
EBITDA | -92.85M | -117.21M | 79% |
Gain YTD | -14.806 | -43.149 | 34% |
P/E Ratio | N/A | N/A | - |
Revenue | 93K | 2.68M | 3% |
Total Cash | 67.5M | 198M | 34% |
Total Debt | 62.5M | 54.6M | 114% |
GUTS | IPSC | |
---|---|---|
RSI ODDS (%) | 1 day ago90% | N/A |
Stochastic ODDS (%) | 1 day ago90% | 1 day ago89% |
Momentum ODDS (%) | 4 days ago83% | 1 day ago80% |
MACD ODDS (%) | N/A | 1 day ago74% |
TrendWeek ODDS (%) | 1 day ago82% | 1 day ago81% |
TrendMonth ODDS (%) | 1 day ago75% | 1 day ago80% |
Advances ODDS (%) | 5 days ago82% | 8 days ago82% |
Declines ODDS (%) | 1 day ago90% | 1 day ago90% |
BollingerBands ODDS (%) | 1 day ago90% | 1 day ago90% |
Aroon ODDS (%) | 1 day ago83% | 1 day ago81% |
A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with CABA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then CABA could also see price increases.
Ticker / NAME | Correlation To GUTS | 1D Price Change % | ||
---|---|---|---|---|
GUTS | 100% | -4.62% | ||
CABA - GUTS | 36% Loosely correlated | -0.84% | ||
YMAB - GUTS | 36% Loosely correlated | N/A | ||
IPSC - GUTS | 35% Loosely correlated | -0.93% | ||
AKBA - GUTS | 35% Loosely correlated | +0.71% | ||
GLUE - GUTS | 35% Loosely correlated | +1.00% | ||
More |
A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.
Ticker / NAME | Correlation To IPSC | 1D Price Change % | ||
---|---|---|---|---|
IPSC | 100% | -0.93% | ||
CRSP - IPSC | 55% Loosely correlated | +1.46% | ||
IMNM - IPSC | 50% Loosely correlated | +6.82% | ||
NTLA - IPSC | 49% Loosely correlated | +2.83% | ||
ABCL - IPSC | 49% Loosely correlated | N/A | ||
BEAM - IPSC | 47% Loosely correlated | N/A | ||
More |